RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVGN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Evogene Ltd stock after losing 3.75%
(Updated on Jul 03, 2024)

Sell candidate since May 31, 2024 Loss -13.44% PDF

The Evogene Ltd stock price fell by -3.75% on the last day (Wednesday, 3rd Jul 2024) from $0.670 to $0.645. During the last trading day the stock fluctuated 5.57% from a day low at $0.625 to a day high of $0.660. The price has been going up and down for this period, and there has been a -1.9% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -44 thousand shares and in total, 38 thousand shares were bought and sold for approximately $24.44 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.18% during the next 3 months and, with a 90% probability hold a price between $0.521 and $0.737 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVGN Signals & Forecast

There are mixed signals in the stock today. The Evogene Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.653 and $0.687. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Thursday, June 20, 2024, and so far it has risen 4.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Evogene Ltd stock

Evogene Ltd finds support from accumulated volume at $0.641 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0348 between high and low, or 5.57%. For the last week the stock has had daily average volatility of 8.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EVGN) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Evogene Ltd to open at $0.643, and during the day (based on 14 day Average True Range), to move between $0.598 and $0.691, which gives a possible trading interval of +/-$0.0464 (+/-7.20%) up or down from last closing price. If Evogene Ltd takes out the full calculated possible swing range there will be an estimated 14.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.641 (0.64%) than the resistance at $0.686 (6.42%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Evogene Ltd stock A Buy?

Evogene Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.314 Sell Candidate Unchanged

Predicted Opening Price for Evogene Ltd of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$0.643 ( 0.258%) $0.645

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVGN

Fibonacci Support & Resistance Levels

Level Price
R3 0.678 5.14%
R2 0.665 3.08%
R1 0.657 1.80%
Price 0.645
S1 0.630 -2.32%
S2 0.622 -3.59%
S3 0.608 -5.65%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.789 22.36%
R2 0.720 11.66%
R1 0.686 6.42%
Price 0.645
S1 0.641 -0.636%
S2 0.625 -3.07%
S3 0.615 -4.62%

FAQ

What is the symbol for Evogene Ltd Stock and on which exchange is it traded?
The symbol for Evogene Ltd is EVGN and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Evogene Ltd Stock?
Evogene Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Evogene Ltd Stock?
Evogene Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evogene Ltd Stock.

What's the current price of Evogene Ltd Stock?
As of the end of day on the Jul 03, 2024, the price of an Evogene Ltd (EVGN) share was $0.645.

What is the 52-week high and low for Evogene Ltd Stock?
The 52-week high for Evogene Ltd Stock is $1.44 and the 52-week low is $0.450.

What is the market capitalization of Evogene Ltd Stock?
As of the Jul 03, 2024, the market capitalization of Evogene Ltd is 32.622M.

When is the next earnings date for Evogene Ltd?
The upcoming earnings date for Evogene Ltd is Aug 15, 2024.
Click to get the best stock tips daily for free!

About Evogene Ltd

Evogene Ltd Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover... EVGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT